Plenary
Programme sponsor
Tuesday 26 September
In June 2021, David became the IBMS Chief Executive following leading the NHS England and Improvement Pathology consolidation programme as Head of Pathology for NHS England and NHS Improvement. He led England’s pathology services in the national response to the COVID-19 pandemic, ensuring that NHS laboratories were able to respond to the national need in standing up the required testing at pace and scale.
For three years running, David was recognised as being one of the top 100 most powerful advocates for pathology in the global community by The Pathologist magazine (2018, 2019 and 2020).
Previously, as an elected IBMS Council Member for the London region, David was chair of the Membership and Marketing Committee. He has also represented the IBMS on NICE diagnostic advisory panels, and various national forums, including an observer on the Royal College of Pathologist Council and in the Parliamentary and Science committee.
In October 2020, the Royal College of Pathologists awarded David Honorary Fellowship in recognition of his contribution to pathology.
Delivering the IBMS strategy Tuesday @ 3:20 PM
National Point-of-Care Strategy Thursday @ 3:00 PM